Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Revenues
Cost and expenses:
Depreciation	22,777	13,070
Research and development	7,302,923	1,967,007
General and administrative	10,635,881	8,702,596
Total costs and expenses	17,961,581	10,682,673
Operating loss	(17,961,581)	(10,682,673)
Interest income	18,811	27,905
Net loss	$ (17,942,770)	$ (10,654,768)
Net loss per share — basic and diluted (in dollars per share)	$ (0.51)	$ (0.66)
Weighted average number of common shares — basic and diluted (in shares)	35,522,875	16,026,980